Literature DB >> 19561887

Using arm span to derive height: impact of three estimates of height on interpretation of spirometry.

S K Chhabra1.   

Abstract

BACKGROUND: When standing height required to calculate forced vital capacity (FVC) cannot be measured, it can be derived from arm span using different methods.
OBJECTIVES: To compare three different estimates of height derived from arm span and investigate their impact on interpretation of spirometric data.
METHODS: In a cross-sectional study, 517 subjects aged 7 to 76 years, with various respiratory diseases underwent spirometry. Three estimates of height were obtained from arm span: (a) by direct substitution (Ht(AS)); (b) estimated height (Ht(est)), obtained from the mean arm span:standing height ratio; and (c) predicted height (Ht(pred)), obtained from arm span by linear regression analysis. Predicted values of forced vital capacity (FVC) obtained from these estimates were compared with those obtained from actual standing height (Ht(act)), followed by Bland Altman analysis of agreement in the patterns of ventilatory impairment.
RESULTS: The arm span was 5%-6% greater than the height. The difference increased with increasing height. Ht(AS) and the FVC predicted from it were significantly greater than the other measures of height and the related predicted FVCs respectively. Compared to Ht(act), Ht(AS) gave a misclassification rate of 23.7% in taller subjects (Ht(act) > 150 cm) and 14.2% in shorter subjects in the patterns of ventilatory impairment. Misclassification rates were 6%-8% with Ht(est) and Ht(pred). Agreement analysis showed that FVCs predicted from Ht(pred) had the best agreement with the FVC predicted from Ht(act).
CONCLUSIONS: Among several methods of estimating height from the arm span, prediction by regression is most appropriate as it gives least errors in interpretation of spirometric data.

Entities:  

Keywords:  Arm span; interpretation; spirometry

Year:  2008        PMID: 19561887      PMCID: PMC2700438          DOI: 10.4103/1817-1737.39574

Source DB:  PubMed          Journal:  Ann Thorac Med        ISSN: 1998-3557            Impact factor:   2.219


Assessment of lung function by spirometry constitutes an important part of diagnostic work-up of a patient with respiratory disease.[12] Interpretation requires comparison of observed with normal values that are obtained from prediction equations. Standing height and age are the major determinant variables of forced vital capacity (FVC) and explain most of its variance.[3] In patients unable to stand straight due to physical disability, structural defects such as kyphoscoliosis or neuromuscular weakness or leg amputation, standing height can be estimated from arm span measurements.[4-10] This may be done by direct substitution by the latter[4-610] or by application of a fixed correction factor based on arm span:height ratio[11] or by estimating height from arm span using regression equations.[7-9] For reasons of simplicity, direct substitution by arm span has been favored, both in children[4] and adults.[510] The errors introduced by such substitution in interpretation of spirometric data have been reported to be small.[46] The recent joint statement of the American Thoracic Society (ATS) and the European Respiratory Society (ERS) has also recommended such substitution.[3] However, the agreement between arm span and standing height has been found to be poor.[812] Direct substitution of arm span for height was also questioned recently by Golshan et al.,[9] who found estimation from regression models to be superior in healthy subjects. As these three methods may not provide similar estimates of standing height, the predicted values will differ and could have an impact on interpretation. An agreement analysis of predicted vital capacity values obtained from height estimated by different methods from the arm span, as well as an evaluation of the impact of predicted vital capacity values on interpretation of spirometric data in patients suffering from respiratory diseases, has not been done. Therefore, the present study was carried out.

Material and Methods

The study protocol was approved by the institutional ethics committee. Patients, both children and adults, suffering from different respiratory diseases and referred to the Pulmonary Function Laboratory of our institute were considered for inclusion in the study. The inclusion criteria were an ability to stand erect for measurement of standing height, absence of any spinal and other skeletal abnormality of the limbs, and performance of acceptable spirometry maneuvers as per the ATS recommendations.[1] It was a cross-sectional study. A total of 550 subjects were screened and 517 were found eligible. There were 287 male and 230 female subjects. The age ranged from 7 to 76 years. The purpose of the study was explained and consent taken. Standing height (actual height, Htact) was measured with a stadiometer in barefoot condition with head in the Frankfurt plane. Arm span (AS) was measured while the patients were asked to stand with their backs against the wall and arms spread in a straight line parallel to the floor. It was measured from the tip of the middle finger of the right hand to the tip of the middle finger of the left hand across the chest at the clavicles. All readings were taken to the nearest 0.5 cm. All the measurements were performed thrice, and the mean was taken and rounded off to the nearest centimeter. Arm span used as a surrogate for height was labeled as HtAS. Besides Htact and HtAS, two additional measures of stature were derived. Estimated height (Htest) was obtained by dividing the AS with the mean AS:Htact ratio. As the AS:Htact ratio was not different in males and females, the mean of the whole sample was used. Predicted height (Htpred) was obtained by developing a linear regression equation with arm span as the independent variable. Spirometry was performed on a dry rolling-seal spirometer of the Benchmark model lung function machine (P. K. Morgan, Kent, UK). Maximal expiratory flow volume curves were obtained as per the ATS 1995 recommendations.[1] Three acceptable and at least two reproducible curves were obtained in each subject. The highest values of FVC and FEV1 were selected. Predicted values of FVC were calculated using regression equations for healthy north Indian adults[13] and children.[14] Forced vital capacity (FVC) obtained from Htact was taken as the reference and labeled as FVC-Htact. Predicted FVCs were obtained from other three measures of stature and labeled as FVC-HtAS, FVC-Htest, and FVC-Htpred. The lower limits of normal (LLN) for FVC were calculated as the difference between the predicted value and 1.645 times the standard error of estimate (SEE). An FEV1/FVC <70% with FVC in the normal range was taken to indicate an ‘obstructive disorder.’ An FVC below LLN with a normal FEV1/FVC ratio was labeled as ‘restrictive disorder.’ An FEV1/FVC <70% with an FVC below LLN was labeled as a ‘mixed disorder.’ An FEV1/FVC ≥70% and FVC above LLN was labeled as ‘normal spirometry.’ Statistical analysis was done using SPSS 11.0 and GraphPad Prism 4.01 for Windows. Data was expressed as mean (sd). Comparisons between two groups were carried out using unpaired paired t test. Comparison of multiple groups was done using the analysis of variance followed by Bonferroni's multiple comparison test to identify significantly different groups. Coefficients of correlations in bivariate relationships were obtained using the Pearson's correlation test. Agreement between various sets of measurements was evaluated by calculating the kappa value for nominal variables and by the Bland Altman analysis for continuous variables. Kappa values were interpreted as recommended by Byrt et al.[15] Linear regression analysis was used to predict Htpred from the arm span. Statistical significance of differences was assumed at P < .05.

Results

The mean (sd) age was 37.4 (17.97) and 34.95 (15.38) years in males and females respectively. The descriptive data of standing height (Htact) and arm span (AS) is shown in Table 1. In an overwhelming majority of the subjects (97.8%), the arm span exceeded height by a mean of 9.66 cm and 8.09 cm in male and female subjects respectively. There was no gender difference (P > .05). The difference was 5.9% in males and 5.4% in females.
Table 1

Descriptive data of standing height and arm span

Males (n = 287)Females (n = 230)
Mean (sd)age37.4 (17.97)34.95 (15.38)
Mean (sd) height (cm)162.89 (12.38)150.85 (8.33)
Height range (cm)107-184110-168
Mean (sd)arm span (cm)172.55 (13.99)158.94 (10.17)
Arm span range107-197111-196
Arm span/height1.0591.054
Arm span-height difference (5th-95th percentile) (cm)2 -16.531.18 -15.15
Mean (sd) arm span-height difference (cm)9.66 (4.21)8.09 (4.61)
Median arm span-height difference (cm)9.338.00
Patients with arm span > height284223
Patients with arm span = height10
Patients with arm span < height27
Descriptive data of standing height and arm span Htact and arm span were well correlated (r = 0.95, P < .0001). However, Bland Altman analysis showed a substantial lack of agreement between the two. The mean difference (sd) was –8.93 (4.46) cm with the 95% limits of agreement of –17.68 to –0.19. A definite trend was observed with increasing difference between the two in taller subjects [Figure 1]. A visual inspection of the scatter plot of AS – Htact against Htact [Figure 2] revealed that the difference increased with increasing Htact and reached a plateau at Htact = 150 cm. The subjects were therefore divided into two groups: group A, Htact ≥ 151 cm (n = 397); and group B, Htact ≤ 150 cm (n = 120). With this division, the relationship between AS – Htact and Htact no longer remained significant in group A (r = 0.18, P > .05), while it remained significant in group B (r = 0.40, P < .0001). Due to this relationship between AS – Htact and Htact, subsequent analysis was carried out separately in the two groups.
Figure 1

Bland Altman plot of Htact and arm span. Horizontal line represents the bias

Figure 2

Scatter plot of AS - Htact against Htact

Bland Altman plot of Htact and arm span. Horizontal line represents the bias Scatter plot of AS - Htact against Htact The linear regression analysis with arm span as the independent variable and Htpred as dependent variable yielded the following equation in group A: Htpred = 33.05 + (0.753 × AS) (r2 = 0.78, standard expected error, 3.597). In group B, the equation was Htpred = 30.47 + (0.745 × AS) (r2 = 0.89, SEE, 3.51). The four measurements of stature in the two groups are shown in Table 2. ANOVA revealed significant differences (P < .0001) among these in both the groups. Between-group comparisons showed that while HtAS was significantly greater than Htact, Htest, and Htpred (P < .001 for each comparison), the other three were not significantly different on paired comparisons in either group (P > .05).
Table 2

Comparison of the four measures of stature and predicted FVC obtained from these

Group AGroup B


Measure of stature***Predicted FVC***Measure of stature***Predicted FVC***
Htact = 162.5 (7.67)3.56 (0.65)Htact = 141.1 (10.33)2.47 (0.39)
HtAS = 171.95 (9.00)3.98 (0.72)HtAS = 148.4 (13.03)2.74 (0.44)
Htest = 162.5 (8.51)3.56 (0.66)Htest = 141.2 (12.41)2.47 (0.42)
Htpred = 162.53 (6.77)3.56 (0.60)Htpred = 141 (9.72)2.47 (0.37)

Data shown as mean (sd);

ANOVA P < 0.0001

Comparison of the four measures of stature and predicted FVC obtained from these Data shown as mean (sd); ANOVA P < 0.0001 Predicted FVC (in L) from the four measures of stature revealed significant differences in both the groups (Table 2, ANOVA, P < .0001). The FVC predicted from HtAS was significantly greater than each of the other three FVCs (P < .001), while there were no differences among the latter three estimates on paired comparisons in either group (P > .05). Results of Bland Altman analysis to examine the agreement between FVC predicted from Htact and that predicted from the other three estimates of height are shown in Table 3 and Figures 3 to 8. In both the groups, the mean difference between FVC-Htact and FVC-HtAS was large with wide limits of agreement. A trend of increasing difference was observed with increasing average of the two [Figures 3 and 6]. On the other hand, the mean difference between FVC-Htact and FVC-Htest and between FVC-Htact and FVC-Htpred was smaller in both the groups. The scatter around the bias line was uniform [Figures 4 and 5, 7 and 8]. The 95% limits of agreement were narrower and similar between FVC-Htact and FVC-Htest and between FVC-Htact and FVC-Htpred in group A. In group B, the 95% limits of agreement between FVC-Htact and FVC-Htpred were even narrower than those between FVC-Htact and FVC-Htest.
Table 3

Results of Bland Altman analysis of agreement between FVC predicted from Htact and that predicted from other measures of stature

Group AGroup B


Mean difference (bias) and (SD)95% limits of agreementMean difference (bias) and (SD)95% limits of agreement
FVC-Htact, FVC-HtAS−0.42 (0.21)−0.81 to 0.021−0.27 (0.17)−0.61 to 0.07
FVC-Htact, FVC-Htest−0.003 (0.17)−0.35 to 0.34−0.001 (0.16)−0.32 to 0.31
FVC-Htact, FVC-Htpred−0.003 (0.17)−0.35 to 0.34−0.002 (0.13)−0.26 to 0.25

Unit of FVC: L

Figure 3

Group A. Bland Altman plot of FVC-Htact and FVC-HtAS. Horizontal line represents the bias

Figure 8

Group B. Bland Altman plot of FVC-Htact and FVC-Htpred. Horizontal line represents the bias

Figure 6

Group B. Bland Altman plot of FVC-Htact and FVC-HtAS. Horizontal line represents the bias

Figure 4

Group A. Bland Altman plot of FVC-Htact and FVC-Htest. Horizontal line represents the bias

Figure 5

Group A. Bland Altman plot of FVC-Htact and FVC-Htpred. Horizontal line represents the bias

Figure 7

Group B. Bland Altman plot of FVC-Htact and FVC-Htest. Horizontal line represents the bias

Results of Bland Altman analysis of agreement between FVC predicted from Htact and that predicted from other measures of stature Unit of FVC: L Group A. Bland Altman plot of FVC-Htact and FVC-HtAS. Horizontal line represents the bias Group A. Bland Altman plot of FVC-Htact and FVC-Htest. Horizontal line represents the bias Group A. Bland Altman plot of FVC-Htact and FVC-Htpred. Horizontal line represents the bias Group B. Bland Altman plot of FVC-Htact and FVC-HtAS. Horizontal line represents the bias Group B. Bland Altman plot of FVC-Htact and FVC-Htest. Horizontal line represents the bias Group B. Bland Altman plot of FVC-Htact and FVC-Htpred. Horizontal line represents the bias The interpretation of spirometry results using the four measures of stature to calculate predicted FVC is shown in Table 4. In group A, out of 397 subjects, 303 were interpreted similarly by HtAS and Htact, giving a misclassification rate of 23.7% (kappa value for agreement, 0.68, indicating a good agreement). With Htest, 367 subjects were categorized similarly as done with Htact, giving a misclassification rate of 8.4% (kappa value for agreement, 0.89, indicating a very good agreement). Finally, categorization was similar in 373 subjects by Htact and Htpred, giving a misclassification rate of 6% (kappa value for agreement, 0.88, indicating a very good agreement). In group B, out of 120 subjects, 103 subjects were interpreted similarly by HtAS and Htact (misclassification rate of 14.2%; kappa value for agreement, 0.8, indicating a good agreement). Using Htest, 112 subjects were categorized similarly as done by Htact, giving a misclassification rate of 6.7% (kappa value for agreement, 0.90, indicating a very good agreement). Finally, categorization was similar in 110 subjects by Htact and Htpred, giving a misclassification rate of 8.3% (kappa value for agreement, 0.88, indicating a very good agreement).
Table 4

Interpretation of spirometry results using the four measures of stature

HtactHtASHtestHtpred
Group A
 Normal184 (46.3)127 (32)191 (48.1)189 (47.6)
 Obstructive80 (20.2)43 (10.8)77 (19.4)77 (19.4)
 Restrictive58 (14.6)115 (29)51 (12.8)53 (13.4)
 Mixed75 (18.9)112 (28.2)78 (19.6)78 (19.6)
Group B
 Normal53 (44.2)40 (33.3)55 (45.8)49 (40.8)
 Obstructive19 (15.8)15 (12.5)21 (17.5)21 (17.5)
 Restrictive30 (25)43 (35.8)28 (23.3)34 (28.3)
 Mixed18 (15)22 (18.3)16 (13.3)16 (13.3)

Figures in parenthesis are column percentages

Interpretation of spirometry results using the four measures of stature Figures in parenthesis are column percentages

Discussion

The results of the study show that arm span was about 5 to 6% greater than the standing height. The difference increased with increasing height and was similar in males and females. Height estimated from a fixed correction factor derived from the arm span:height ratio and/or predicted from arm span using a linear regression equation yielded a value closer to actual standing height than using the arm span as a substitute. Therefore, predicted FVC calculated by using arm span instead of actual height was substantially higher than that obtained using the other two estimates of height. This resulted in large errors in interpretation of spirometric data. Substitution of arm span for actual height resulted in erroneous interpretation in almost one quarter of the subjects taller than 150 cm and in about 15% of the shorter subjects. The errors in interpretation with the other two estimates of height were smaller (6% to 8%) and similar. The correlation between standing height and arm span is usually excellent.[48] Therefore, when actual standing height cannot be measured or is affected by disease as in thoracic vertebral compression due to osteoporosis, and deformity in kyphoscoliosis, arm span has been recommended as a substitute for calculation of the predicted FVC.[24510] Parker et al.[11] observed that fixed arm span-to-height ratios may also be used to estimate height with reasonable accuracy, but there were errors at extremes of stature. Aggarwal et al.[6] observed that height obtained by substitution of arm span or estimation by ratio method resulted in similar errors in interpretation of spirometric data. The errors were however substantial, 16.22% and 14.04% subjects being wrongly classified respectively. They did not evaluate the utility of predicting height from arm span by regression analysis. In a recent study, Golshan et al.[9] found that arm span substitution for height over-predicted FVC in healthy subjects compared to FVC calculated from height obtained by regression equations. They did not evaluate the impact of different methods to obtain height on interpretation of spirometry data in patients. A good correlation does not necessarily mean a good agreement. Torres et al.[8] and Hickson and Frost,[12] applying the Bland Altman analysis, observed a poor agreement between the arm span and height even though these correlate well. Hence substitution is not justified. Our observations corroborate these. In addition, we found that height estimated from arm span using a fixed ratio or regression gave similar FVC. This is the first study to report on the impact of these three different estimates of height from arm span on spirometric interpretation in patients with respiratory diseases. The greater misclassification with direct substitution of arm span for actual height resulted from shifts from normal and obstructive categories to restrictive and mixed categories. This can be explained as arm span yields higher predicted FVC and observed values in patients are more likely to fall below the lower limits of normal and thus get classified as ‘restrictive.’ The misclassification was also greater in taller subjects. Yun et al.[16] have reported earlier that growth rates of arm span were greater than those of height in general. In agreement with this, we also observed the difference (arm span – actual height) to increase with height and peaking when the latter reached 150 cm. Thus the over-prediction of FVC on using arm span would be greater in taller subjects. This aspect of the relationship between arm span and standing height was not examined in earlier studies.[69] The misclassification has significant clinical implications. There is a risk of wrongly labeling a normal subject as abnormal, as well as overestimating the degree of impairment in those with a true restrictive pathology. Therefore, the practice of substituting arm span for height cannot be recommended. The FVC predicted by the other two estimates of height was closer to that predicted from actual height, and thus overall agreement in interpretation of spirometry was also very good. Yet the limits of agreement between FVC obtained from these estimates and that obtained from actual height were fairly wide on Bland Altman analysis and therefore, the clinician needs to be careful in interpretation of spirometric data using estimated heights, especially when the values are closer to the lower limits of normal. From the results of this study, it appears that when actual height cannot be obtained, either of the two measures may be used in taller subjects. In shorter subjects, however, height predicted from arm span using regression agrees more closely with actual height than does that estimated using a fixed ratio and is therefore recommended. The study has limitations. It was not blinded. The population of the study was divided into two groups after the study was completed. This, however, was not possible before the study as the relationship between (arm span – height) and height was not known. Further, generalization to other ethnic backgrounds may not be done as arm span and height correlations have been shown to be different among different ethnic groups. Similar studies therefore need to be carried out in other populations. In conclusion, when actual height cannot be measured, prediction from arm span using regression analysis appears to be the most appropriate method as it predicts vital capacity closer to the actual and gives least errors in interpretation of spirometric data in patients with respiratory diseases. Direct substitution of arm span for height is not recommended as it yields greater than true predicted vital capacity, resulting in unacceptably high rates of misclassification of spirometric data.
  15 in total

1.  Substitution of arm span for standing height is important for the assessment of predicted value of lung volumes in elderly people with osteoporosis.

Authors:  S Teramoto; T Matsuse; Y Ouchi
Journal:  Chest       Date:  1999-12       Impact factor: 9.410

2.  Is arm span an accurate measure of height to predict pulmonary function parameters?

Authors:  M Golshan; B Amra; M A Hoghoghi
Journal:  Monaldi Arch Chest Dis       Date:  2003 Jul-Sep

3.  Arm span-height relationships in patients referred for spirometry.

Authors:  J M Parker; T A Dillard; Y Y Phillips
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

4.  How good is that agreement?

Authors:  T Byrt
Journal:  Epidemiology       Date:  1996-09       Impact factor: 4.822

5.  Standardization of Spirometry, 1994 Update. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

6.  Pulmonary function tests in healthy children.

Authors:  S K Malik; S K Jindal
Journal:  Indian Pediatr       Date:  1985-09       Impact factor: 1.411

7.  Correlations among height, leg length and arm span in growing Korean children.

Authors:  D J Yun; D K Yun; Y Y Chang; S W Lim; M K Lee; S Y Kim
Journal:  Ann Hum Biol       Date:  1995 Sep-Oct       Impact factor: 1.533

8.  Interpreting spirometric data: impact of substitution of arm span for standing height in adults from North India.

Authors:  A N Aggarwal; D Gupta; S K Jindal
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

9.  Relationship of lung function to severity of osteoporosis in women.

Authors:  J A Leech; C Dulberg; S Kellie; L Pattee; J Gay
Journal:  Am Rev Respir Dis       Date:  1990-01

10.  Relation of armspan to height and the prediction of lung function.

Authors:  M E Hibbert; A Lanigan; J Raven; P D Phelan
Journal:  Thorax       Date:  1988-08       Impact factor: 9.139

View more
  8 in total

1.  ARTP statement on pulmonary function testing 2020.

Authors:  Karl Peter Sylvester; Nigel Clayton; Ian Cliff; Michael Hepple; Adrian Kendrick; Jane Kirkby; Martin Miller; Alan Moore; Gerrard Francis Rafferty; Liam O'Reilly; Joanna Shakespeare; Laurie Smith; Trefor Watts; Martyn Bucknall; Keith Butterfield
Journal:  BMJ Open Respir Res       Date:  2020-07

2.  Arm span as a predictor of the six-minute walk test in healthy children.

Authors:  Buse Ozcan Kahraman; Ertugrul Yuksel; Abdurrahman Nalbant; Umut Ziya Kocak; Bayram Unver
Journal:  Braz J Phys Ther       Date:  2020-07-30       Impact factor: 3.377

3.  Estimated kidney function in children and young adults with spina bifida: A retrospective cohort study.

Authors:  David I Chu; Lauren C Balmert; Cameron M Arkin; Theresa Meyer; Ilina Rosoklija; Belinda Li; Kavita S Hodgkins; Susan L Furth; Earl Y Cheng; Elizabeth B Yerkes; Tamara Isakova
Journal:  Neurourol Urodyn       Date:  2019-07-08       Impact factor: 2.696

4.  Non-invasive pulmonary function test on Morquio patients.

Authors:  Francyne Kubaski; Shunji Tomatsu; Pravin Patel; Tsutomu Shimada; Li Xie; Eriko Yasuda; Robert Mason; William G Mackenzie; Mary Theroux; Michael B Bober; Helen M Oldham; Tadao Orii; Thomas H Shaffer
Journal:  Mol Genet Metab       Date:  2015-06-23       Impact factor: 4.797

5.  Evaluation of effects of continued corticosteroid treatment on cardiac and pulmonary function in non-ambulatory males with Duchenne muscular dystrophy from MD STARnet.

Authors:  Russell J Butterfield; Sergey Kirkov; Kristin M Conway; Nicholas Johnson; Dennis Matthews; Han Phan; Bo Cai; Pangaja Paramsothy; Shiny Thomas; Marcia L Feldkamp
Journal:  Muscle Nerve       Date:  2022-01-20       Impact factor: 3.852

6.  Impact of direct substitution of arm span length for current standing height in elderly COPD.

Authors:  Chaicharn Pothirat; Warawut Chaiwong; Nittaya Phetsuk
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-22

7.  Estimation of true height: a study in population-specific methods among young South African adults.

Authors:  Christen Renée Lahner; Susanna Maria Kassier; Frederick Johannes Veldman
Journal:  Public Health Nutr       Date:  2016-09-09       Impact factor: 4.022

8.  Eighteen Years with Spinal Muscular Atrophy (SMA) Type 1.

Authors:  Borja Valencia; John Robert Bach
Journal:  Tanaffos       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.